Hybrid alternative for postinfarction VSR: the SurCOP strategy
Description and outcomes of a hybrid strategy for the management of postinfarction VSR.
Heart Surgery Today
RecoverHeart: estimating myocardial recovery before implanting a ventricular assist device
Multicenter development and external validation study, with a prominent contribution from the Utah group, proposing a calculator to estimate—before implantation—the individual probability of significant reverse remodeling in patients with advanced heart failure treated with a durable left ventricular assist device.
Biological circulatory support: cardiac xenotransplantation as a bridge in infants
Preclinical study of pig-to-baboon cardiac xenotransplantation as a bridge to allotransplantation.
Can a simple angle compromise a coronary bypass graft? The importance of geometry in sequential arterial revascularization
This study examines the impact of the angle formed at the sequential anastomosis to a diagonal branch (D-angle) in patients undergoing total arterial coronary revascularization with different graft configurations. Variations in the width of this angle may compromise flow through the distal segment of the graft.
LVAD vs heart transplantation in middle-aged patients: which treatment should be considered first?
This study aimed to determine which strategy provides the greatest net survival benefit as the initial therapeutic option for middle-aged patients with advanced heart failure: heart transplantation or left ventricular assist device therapy.
A second chance in minimally invasive mitral valve repair?
This study evaluates the safety and short- and mid-term outcomes of performing second aortic cross-clamping (2nd XCL) in patients undergoing minimally invasive mitral valve repair (MI-MVr) when the initial repair does not achieve an acceptable result.
Anesthesia for congenital heart disease in 2025: from uniform protocols to individualized decision-making
A narrative review aimed at anesthesiologists, intensivists, and multidisciplinary teams, structured around several major areas, including the care of adults with congenital heart disease, cardiopulmonary bypass and coagulation management, enhanced recovery programs, and the safety of noncardiac procedures.
Partner 2 at 10 years: surgery should remain a valid option in intermediate-risk patients
This study analyzes the 10-year clinical and echocardiographic outcomes of the randomized PARTNER 2A trial, which compared transcatheter aortic valve implantation using transfemoral or transthoracic transapical or transaortic access with the SAPIEN XT prosthesis versus surgery in patients with severe symptomatic aortic stenosis and intermediate surgical risk.
When does waiting cease to be harmless? Follow-up of left-to-right shunts
A clinical guidance document focusing on the timing of surveillance and treatment across the different forms of congenital heart disease caused by left-to-right shunting.
DCD heart donation: Europe and the United States, two ways to widen the same pool
Observational, retrospective, multicenter study comparing donors, recipients, retrieval techniques, and outcomes of DCD heart transplantation in Europe and the United States.